MediOrbisTM Partners with Kahun to Offer Artificial Intelligence Powered Digital Intake and Triage Services

MediOrbis, a multi-specialty telehealth company with comprehensive specialty telemedicine services and chronic disease management (CDM) programs, is partnering with Kahun to offer Kahun's proprietary AI-driven digital intake tool as a part of its comprehensive telehealth platform. Effective immediately, MediOrbis clients can now access this industry-leading tool as a means of providing patient information, streamlining telehealth visits, engaging patients and assisting providers in managing telemedicine consultations.

Kahun
ReBlonde

Kahun's XAI-driven (explainable AI) clinical reasoning tool performs dynamic clinical assessments at scale, basing its decisions on the company's proprietary map of more than 30 million evidence-based medical insights. By mimicking the clinical thinking process and leveraging its map of medical knowledge, Kahun generates professional clinical insights for physicians prior to the patient visit.

"MediOrbis exemplifies what we refer to as 'new telemedicine,' by providing comprehensive, whole-person digital care," says Dr. Jonathan Wiesen, M.D., the co-founder and chief medical officer of MediOrbis. "In addition to our existing longitudinal clinical services, we are providing a digital intake service to patients, thereby ensuring that they have access to the best information to give them as much information as possible prior to being seen by a provider, and assisting patients and physicians in streamlining the intake process for telemedicine consultations. The MediOrbis platform can therefore support digital triage initiatives of health systems, health plans and self-insured payers. In this way, we can truly care for patients from one access point for all of their medical-related needs, by providing them both the best telehealth programs, episodic and longitudinal, and also guide them to the care that is most appropriate for their specific concerns."

"We are thrilled to partner with MediOrbis, a major player in the field of digital healthcare," says Eitan Ron, CEO and Co-Founder of Kahun. "As the demand for telehealth rises, we're expediting the clinical intake process and relieving burnout for physicians by providing them with valuable clinical information before they even meet the patient, which can actually help them optimize the clinical visit."

Already a global leader in worldwide specialty telemedicine by improving access to high quality specialty care and providing first-to-market capabilities for managing chronic conditions, such as heart disease, chronic lung disease, diabetes and chronic kidney disease, MediOrbis is poised to deliver further value to its clients with this additional offering. In this way, healthcare services can be unified through one simple platform, and clients can utilize one contact point to organize all their member's healthcare needs.

With years of outstanding worldwide telemedicine service, conducting thousands of telemedicine patient consultations per month, the MediOrbis team continues to provide innovative and cost-efficient global solutions, leveraging digital care to address and manage specialty and chronic illnesses - the most prevalent and resource-consumptive health conditions. With the introduction of this new program, MediOrbis expects the payer community to take advantage of this opportunity to address complex diseases and conditions, achieve better patient outcomes, reduce hospital admissions and lower costs. This is of even greater value to members in rural areas who lack adequate access to necessary wellness and health resources.

"We focus on improving patient engagement and enhancing the patient experience with telehealth services that answer market demand for more accessible, affordable specialty care," says Wiesen. "We continually seek to innovate and develop meaningful programs that impact the health and well-being of individuals throughout the world while serving the fiduciary and financial concerns of our growing customer base."

ⓒ 2024 TECHTIMES.com All rights reserved. Do not reproduce without permission.
Join the Discussion
Real Time Analytics